Biotech

All Articles

OS Therapies refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.Operating system Therapies will certainly list on the NYSE American stock swap today by means of a ...

ALX's fizzling CD47 feedback fee sends supply spiraling down

.ALX Oncology's phase 2 gastric cancer cells reaction price has weakened. After seeing its CD47 bloc...

Ionis centers eye ailment coming from aim ats of Roche-partnered possibility after information let down

.An Additional of Ionis Pharmaceuticals' key midphase readouts has disappointed requirements, motiva...

Biogen's CEO pointed out no high-risk sell 2023. He's ready to be strong

.While Biogen's pharma peers are seeking for late-stage resources along with little risk, chief exec...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Bio has been actually a biotech searching for a pipe after it junked its own lead possession...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored legal rights to an early Alzheimer's condition plan to Denali Therapie...

Takeda touches brand new head people oncology organization-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and r...

Vertex, beaten by AATD again, drops 2 properties on discard pile

.Tip's attempt to treat a rare hereditary illness has reached one more obstacle. The biotech shook p...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of staff

.Vir Biotechnology's second-quarter incomes file had not been short of large headlines. The provider...

Galapagos pauses CAR-T tissue treatment trial over Parkinsonism instance

.Galapagos has actually stopped application in a trial of a BCMA-directed CAR-T tissue therapy, pump...